Inhibitor of DNA binding（Id）-1 has been identified for nearly 20 years, and it involved in the carcinogenesis of a variety of cancer as an oncogene. This review was focused on Id-1, which included its carcinogenic and effect on angiogenesis, invasion and migration of neoplasms, as well as the potential mechanism of Id-1 in drug resistance of cancer cells.
